Does it all ADA up? Adalimumab for ulcerative colitis

被引：3
|
作者：
Travis, Simon [1 ]
机构：
[1] John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford OX3 9DU, England
来源：
GUT | 2011年 / 60卷 / 06期
关键词：
ACTIVITY INDEXES; THERAPY; INFLIXIMAB; DISEASE;
D O I：
10.1136/gut.2010.233403
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：741 / 742
页数：2
相关论文
共 50 条
  • [1] The economics of adalimumab for ulcerative colitis
    Xie, Feng
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (03) : 373 - 377
  • [2] Adalimumab: A 'Maillon Faible' in the Treatment of Ulcerative Colitis?
    Roblin, Xavier
    Paul, Stephane
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (03): : 337 - 338
  • [3] Successful use of golimumab in a patient with ulcerative colitis refractory to infliximab and adalimumab
    Cortes, Xavier
    Borras-Blasco, Joaquin
    Flor, Laura
    Antequera, Beatriz
    Fernandez-Martinez, Sergio
    Ramon Moles, Jose
    Castera, Elvira
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (03) : 257 - 260
  • [4] Adalimumab for Ulcerative Colitis: Ultra or Just Mediocre COMMENT
    Hudesman, David
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (01) : 217 - 218
  • [5] Adalimumab in ulcerative colitis: hypes and hopes
    Fiorino, Gionata
    Peyrin-Biroulet, Laurent
    Repici, Alessandro
    Malesci, Alberto
    Danese, Silvio
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (01) : 109 - 116
  • [6] Efficacy of Adalimumab as a long term maintenance therapy in ulcerative colitis
    McDermott, Edel
    Murphy, Seamus
    Keegan, Denise
    O'Donoghue, Diarmuid
    Mulcahy, Hugh
    Doherty, Glen
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (02): : 150 - 153
  • [7] Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
    Sands, Bruce E.
    Peyrin-Biroulet, Laurent
    Loftus, Edward V., Jr.
    Danese, Silvio
    Colombel, Jean-Frederic
    Toruner, Murat
    Jonaitis, Laimas
    Abhyankar, Brihad
    Chen, Jingjing
    Rogers, Raquel
    Lirio, Richard A.
    Bornstein, Jeffrey D.
    Schreiber, Stefan
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (13): : 1215 - 1226
  • [8] Adalimumab in ulcerative colitis: Ready for prime time
    Danese, Silvio
    DIGESTIVE AND LIVER DISEASE, 2013, 45 (01) : 8 - 13
  • [9] Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis
    Ignacio Fernandez-Blanco, J.
    Fernandez-Diaz, Guillermo
    Cara, Carlos
    Vera, Maria I.
    Olivares, David
    Taxonera, Carlos
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (03) : 731 - 737
  • [10] Febrile neutropenia associated with adalimumab in a patient with ulcerative colitis
    Abumuhfouz, Ma'In Atallah Mohammad
    Alsadi, Anas
    Umer, Waseem Fadhl
    Habib, Mhd Baraa
    CLINICAL CASE REPORTS, 2024, 12 (04):
12345